MeshFr.i
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « MeshFr.i » - entrée « Vaccins antiviraux »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccins < Vaccins antiviraux < Vaisseaux capillaires  Facettes :

List of bibliographic references indexed by Vaccins antiviraux

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]
Ident.Authors (with country if any)Title
000987 (2020) Pavan Kumar Samudrala [Inde] ; Pramod Kumar [Inde] ; Kamlesh Choudhary [Inde] ; Nagender Thakur [Inde] ; Gaurav Suresh Wadekar [Inde] ; Richa Dayaramani [Inde] ; Mukta Agrawal [Inde] ; Amit Alexander [Inde]Virology, pathogenesis, diagnosis and in-line treatment of COVID-19.
000B01 (2020) The race against COVID-19.
000C45 (2020) Pradip Gyanwali [Népal] ; Sitasma Sharma [Népal] ; Suman Pant [Népal] ; Pallavi Koirala [Népal] ; Kriti Adhikari [Népal] ; Janak Koirala [Népal] ; Meghnath Dhimal [Népal]Safety and Efficacy of Different Therapeutic Interventions on Prevention and Treatment of COVID-19.
000E06 (2020) Satya P. Gupta [Inde]Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2.
000E35 (2020) Saba Shamim [Pakistan] ; Maryam Khan [Pakistan] ; Zelal Jaber Kharaba [Émirats arabes unis] ; Munazza Ijaz [Pakistan] ; Ghulam Murtaza [Pakistan]Potential strategies for combating COVID-19.
000F20 (2020) Fatemeh Oroojalian [Iran] ; Ali Haghbin [Iran] ; Behzad Baradaran [Iran] ; Nima Hemmat [Iran] ; Mohammad-Ali Shahbazi [Iran] ; Hossein Bannazadeh Baghi [Iran] ; Ahad Mokhtarzadeh [Iran] ; Michael R. Hamblin [Afrique du Sud]Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials.
000F26 (2020) H Holden ThorpNot throwing away our shot.
000F41 (2020) Wagner Gouvea Dos Santos [Brésil]Natural history of COVID-19 and current knowledge on treatment therapeutic options.
000F79 (2020) Xiaolei Yang [République populaire de Chine] ; Ye Liu [République populaire de Chine] ; Yuping Liu [République populaire de Chine] ; Qing Yang [République populaire de Chine] ; Xubo Wu [République populaire de Chine] ; Xuan Huang [République populaire de Chine] ; Huijia Liu [République populaire de Chine] ; Weimin Cai [République populaire de Chine] ; Guo Ma [République populaire de Chine]Medication therapy strategies for the coronavirus disease 2019 (COVID-19): recent progress and challenges.
001173 (2020) Ibrahim Yakoub-Agha [France]Hydroxychloroquine in Covid-19: Does the end justify the means?
001290 (2020) D M O. Campos [Brésil] ; C B S. Oliveira [Brésil] ; J M A. Andrade [Brésil] ; J I N. Oliveira [Brésil]Fighting COVID-19.
001316 (2020) Sairam Atluri ; Laxmaiah Manchikanti [États-Unis] ; Joshua A. Hirsch [États-Unis]Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
001331 (2020) Sumita Agrawal [Oman] ; Akhil Dhanesh Goel [Oman] ; Nitesh Gupta [Oman]Emerging prophylaxis strategies against COVID-19.
001339 (2020) Kyle Thomson [États-Unis] ; Herschel Nachlis [États-Unis]Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval.
001449 (2020) Jiancheng Zhang [République populaire de Chine] ; Bing Xie [République populaire de Chine] ; Kenji Hashimoto [Japon]Current status of potential therapeutic candidates for the COVID-19 crisis.
001714 (2020) Wissem Hachfi ; Nadia Ben LasfarCOVID-19: Main therapeutic options.
001744 (2020) Haneen Amawi ; Ghina'A I. Abu Deiab ; Alaa A. A Aljabali ; Kamal Dua [Australie] ; Murtaza M. Tambuwala [Royaume-Uni]COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics.
001791 (2020) Amanda C. Guidon [États-Unis] ; Anthony A. Amato [États-Unis]COVID-19 and neuromuscular disorders.
001903 (2020) Gao Song ; Meng Qun Cheng ; Xian Wen Wei [République populaire de Chine]Analysis of the WHO ICTRP for novel coronavirus clinical trial registrations.
001913 (2020) Anupama M. Gudadappanavar [Inde] ; Jyoti Benni [Inde]An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
001927 (2020) Alex John London [États-Unis] ; Jonathan Kimmelman [Canada]Against pandemic research exceptionalism.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i -k "Vaccins antiviraux" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/MeshFr.i  \
                -Sk "Vaccins antiviraux" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    MeshFr.i
   |clé=    Vaccins antiviraux
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021